JCRB4157 NCC-CDS2-C1

Cell information

Important Notice(s)

Culture medium and substratum for NCC-series of sarcoma cell lines / NCCシリーズ肉腫細胞株の培地と培養基質

NCCシリーズ肉腫由来細胞株の分譲について:営利機関への分譲には細胞樹立機関である国立がん研究センターとの有体物提供契約書の締結が必要です

Conclusion of Material Transfer Agreement with charge (MTA) with National Cancer Center (NCC) is prerequisite for the transfer of NCC-series of sarcoma-derived cell lines to For-profit Organizations.

Cell type:general cells (View Pricing Information)

JCRB No.   JCRB4157 Cell Name   NCC-CDS2-C1
Profile   CIC rearranged sarcoma cell line Other Name   
Animal   human Strain   
Genus   Homo Species   sapiens
Sex   F Age   50-year-old
Identity   available Tissue for Primary Cancer   Left thigh
Case history   CIC rearranged sarcoma Metastasis   
Tissue Metastasized    Genetics   CIC-DUX4(fusion)
Life Span   Not confirmed Crisis PDL   
Morphology   fibroblast-like Character   doubling time: ~28 hr
Classify   tumor Established by   Yuki YOSHIMATSU
Registered by   Tadashi KONDO Regulation for Distribution   Additional MTA (for profit organization)
Comment    Year   2024
Medium   Original medium: DMEM/F-12 medium with 10% FBS. (Current medium for propagation: DMEM/F-12 medium supplemented with GlutaMAX, 5% heat-inactivated fetal bovine serum (FBS), 10 uM Y-27632, 10 ng/mL basic fibroblast growth factor (bFGF), 5 ng/mL epidermal growth factor (EGF), 5 ug/mL insulin, 0.4 ug/mL hydrocortisone.) Methods for Passages   0.1% Trypsin-EDTA
Cell Number on Passage    Race   Japanese
CO2 Conc.   5% Tissue Sampling   Left thigh
Tissue Type   

Detection of virus genome fragment by Real-time PCR
Detected DNA Virus not tested Detected RNA Virus not tested

Reference
Pubmed id:31898195Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
Yoshimatsu Y,Noguchi R,Tsuchiya R,Kito F,Sei A,Sugaya J,Nakagawa M,Yoshida A,Iwata S,Kawai A,Kondo T
Hum Cell. 2020 Apr;33(2):427-436

Images



LOT Information

Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.
Cell No.   JCRB4157 Cell Name   NCC-CDS2-C1
LOT No.   07032026 Lot Specification   distribution
Medium   DMEM/F12 supplemented with GlutaMax(GIBCO #10565018) with 5% heat-inactivated fetal bovine serum (Nichirei Cat. # 174112, Lot 20M00K), 5 ug/mL insulin, 0.4 ug/mL hydrocortisone, 5 ng/mL EGF, 10 ng/mL bFGF and 5 uM Y-27632.Cells were cultured on collagen-coated plate. Temperature   37 C
Cell Density at Seeding   2.3-4.2x10^4 cells/sq.cm Methods for Passages   Cells were harvested after treatment with 0.1% trypsin and 0.02% EDTA
Doubling Time   NT Cell Number in Vial (cells/1ml)   3.0x10^6
Viability at cell freezing (%)   99 Antibiotics Used   free
Passage Number   p35 PDL   NT
Sterility: MYCOPLASMA   - Sterility: BACTERIA   -
Sterility: FUNGI   - Isozyme Analysis   NT
Chromosome Mode   NT Chromosome Information   NT
Surface Antigen   NT DNA Profile (STR)   D5S818:8,11
D13S317:8,11
D7S820:8,9
D16S539:9,11
VWA:14,17
TH01:7,9
AM:X
TPOX:8,9
CSF1PO:10
Adhesion   Yes Exoteric Gene   NT
Medium for Freezing   Cell Banker 1 (Nihon Zenyaku Kogyo Co.Ltd Catalog No. CB011) CO2 Conc.   5%
Viability immediately after thawing (%)   96 Additional information   Cells were cultured on collagen-coated plate.
Images
CLOSE